ARR and NNT or NNH of thromboprophylaxis in cancer patients for the outcomes of VTE, major bleeding, and all-cause mortality with different Khorana risk scores.
Figure 2.

ARR and NNT or NNH of thromboprophylaxis in cancer patients for the outcomes of VTE, major bleeding, and all-cause mortality with different Khorana risk scores.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal